Half-year report · HY
4996.TEDINET S100Y9R9
Period2025-11-01 → 2026-04-30
Filed2026-06-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥102.9bn | 2025-11-01 → 2026-04-30 | Cons. | Net sales |
| Revenue | ¥170.5bn | 2024-11-01 → 2025-10-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥96.2bn | 2024-11-01 → 2025-04-30 | Cons. | Net sales |
| Operating income | ¥10.5bn | 2025-11-01 → 2026-04-30 | Cons. | Operating income |
| Operating income | ¥9.4bn | 2024-11-01 → 2025-04-30 | Cons. | Operating income |
| Ordinary income | ¥13.8bn | 2025-11-01 → 2026-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥13.4bn | 2024-11-01 → 2025-10-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.3bn | 2024-11-01 → 2025-04-30 | Cons. | Ordinary income |
| Profit before tax | ¥12.3bn | 2025-11-01 → 2026-04-30 | Cons. | Income before income taxes |
| Profit before tax | ¥8.4bn | 2024-11-01 → 2025-04-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.7bn | 2025-11-01 → 2026-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥4.4bn | 2024-11-01 → 2025-10-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.3bn | 2024-11-01 → 2025-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.4bn | 2025-11-01 → 2026-04-30 | Cons. | Profit loss |
| Net income | ¥6.4bn | 2024-11-01 → 2025-04-30 | Cons. | Profit loss |
| Total assets | ¥259.1bn | at 2026-04-30 | Cons. | Assets |
| Total assets | ¥248.2bn | at 2025-10-31 | Cons. | Assets |
| Total assets | ¥268.5bn | at 2025-04-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥98.6bn | at 2026-04-30 | Cons. | Liabilities |
| Total liabilities | ¥97.1bn | at 2025-10-31 | Cons. | Liabilities |
| Net assets / equity | ¥160.5bn | at 2026-04-30 | Cons. | Net assets |
| Net assets / equity | ¥151.1bn | at 2025-10-31 | Cons. | Net assets |
| Net assets / equity | ¥156.1bn | at 2025-04-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥27.8bn | at 2026-04-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥22.0bn | at 2025-10-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥27.6bn | at 2026-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.8bn | at 2025-10-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥24.6bn | at 2025-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥27.1bn | at 2024-10-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.2bn | 2025-11-01 → 2026-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥33.8bn | 2024-11-01 → 2025-10-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.4bn | 2024-11-01 → 2025-04-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.6bn | 2025-11-01 → 2026-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.9bn | 2024-11-01 → 2025-10-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.3bn | 2024-11-01 → 2025-04-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥490m | 2025-11-01 → 2026-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥27.9bn | 2024-11-01 → 2025-10-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.1bn | 2024-11-01 → 2025-04-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥72.63 | 2025-11-01 → 2026-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥36.38 | 2024-11-01 → 2025-10-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.11 | 2024-11-01 → 2025-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 59.5% | at 2026-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.2% | at 2025-10-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.5% | at 2025-04-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-11-01 → 2026-04-30 | ¥6.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-11-01 → 2026-04-30 | ¥4.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-11-01 → 2026-04-30 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-11-01 → 2026-04-30 | ¥581m |
| Reconciling Itemsreconciling | revenue | 2025-11-01 → 2026-04-30 | −¥2.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-11-01 → 2026-04-30 | −¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2025-11-01 → 2026-04-30 | −¥1.1bn |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | revenue | 2025-11-01 → 2026-04-30 | ¥83.6bn |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | revenue external | 2025-11-01 → 2026-04-30 | ¥83.6bn |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | revenue intersegment | 2025-11-01 → 2026-04-30 | ¥2m |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | segment profit | 2025-11-01 → 2026-04-30 | ¥9.9bn |
| Chemicalsreportable segment | revenue | 2025-11-01 → 2026-04-30 | ¥14.6bn |
| Chemicalsreportable segment | revenue external | 2025-11-01 → 2026-04-30 | ¥14.5bn |
| Chemicalsreportable segment | revenue intersegment | 2025-11-01 → 2026-04-30 | ¥29m |
| Chemicalsreportable segment | segment profit | 2025-11-01 → 2026-04-30 | ¥1.1bn |
| —segment total | revenue | 2025-11-01 → 2026-04-30 | ¥98.2bn |
| —segment total | revenue external | 2025-11-01 → 2026-04-30 | ¥98.2bn |
| —segment total | revenue intersegment | 2025-11-01 → 2026-04-30 | ¥31m |
| —segment total | segment profit | 2025-11-01 → 2026-04-30 | ¥11.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-11-01 → 2026-04-30 | ¥105.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-11-01 → 2026-04-30 | ¥102.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-11-01 → 2026-04-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-11-01 → 2026-04-30 | ¥11.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-11-01 → 2025-04-30 | ¥7.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-11-01 → 2025-04-30 | ¥5.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-11-01 → 2025-04-30 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-11-01 → 2025-04-30 | ¥535m |
| Reconciling Itemsreconciling | revenue | 2024-11-01 → 2025-04-30 | −¥2.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-11-01 → 2025-04-30 | −¥2.1bn |
| Reconciling Itemsreconciling | segment profit | 2024-11-01 → 2025-04-30 | −¥1.0bn |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | revenue | 2024-11-01 → 2025-04-30 | ¥78.4bn |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | revenue external | 2024-11-01 → 2025-04-30 | ¥78.4bn |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | revenue intersegment | 2024-11-01 → 2025-04-30 | ¥2m |
| Agricultual Chemicals And Agriculture Related Reportable Segments Memberreportable segment | segment profit | 2024-11-01 → 2025-04-30 | ¥9.1bn |
| Chemicalsreportable segment | revenue | 2024-11-01 → 2025-04-30 | ¥12.5bn |
| Chemicalsreportable segment | revenue external | 2024-11-01 → 2025-04-30 | ¥12.5bn |
| Chemicalsreportable segment | revenue intersegment | 2024-11-01 → 2025-04-30 | ¥25m |
| Chemicalsreportable segment | segment profit | 2024-11-01 → 2025-04-30 | ¥822m |
| —segment total | revenue | 2024-11-01 → 2025-04-30 | ¥91.0bn |
| —segment total | revenue external | 2024-11-01 → 2025-04-30 | ¥90.9bn |
| —segment total | revenue intersegment | 2024-11-01 → 2025-04-30 | ¥26m |
| —segment total | segment profit | 2024-11-01 → 2025-04-30 | ¥9.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-11-01 → 2025-04-30 | ¥98.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-11-01 → 2025-04-30 | ¥96.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-11-01 → 2025-04-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-11-01 → 2025-04-30 | ¥10.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 553
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 1669000000 | JPY |
| Other cl | InterimInstant | 3365000000 | JPY |
| Current liabilities | Prior1YearInstant | 74017000000 | JPY |
| Current liabilities | InterimInstant | 78255000000 | JPY |
| Long term loans payable | Prior1YearInstant | 14324000000 | JPY |
| Long term loans payable | InterimInstant | 9807000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 3940000000 | JPY |
| Deferred tax liabilities | InterimInstant | 5683000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 464000000 | JPY |
| Provision for directors retirement benefits | InterimInstant | 408000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 3469000000 | JPY |
| Net defined benefit liability | InterimInstant | 3453000000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 44000000 | JPY |
| Asset retirement obligations ncl | InterimInstant | 129000000 | JPY |
| Other ncl | Prior1YearInstant | 840000000 | JPY |
| Other ncl | InterimInstant | 841000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 23081000000 | JPY |
| Noncurrent liabilities | InterimInstant | 20321000000 | JPY |
| Liabilities | Prior1YearInstant | 97098000000 | JPY |
| Liabilities | InterimInstant | 98576000000 | JPY |
| Capital stock | Prior1YearInstant | 4534000000 | JPY |
| Capital stock | InterimInstant | 4534000000 | JPY |
| Capital surplus | Prior1YearInstant | 37502000000 | JPY |
| Capital surplus | InterimInstant | 37499000000 | JPY |
| Retained earnings | Prior1YearInstant | 110394000000 | JPY |
| Retained earnings | InterimInstant | 117456000000 | JPY |
| Treasury stock | Prior1YearInstant | -9184000000 | JPY |
| Treasury stock | InterimInstant | -9145000000 | JPY |
| Shareholders equity | Prior1YearInstant | 143247000000 | JPY |
| Shareholders equity | InterimInstant | 150345000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 2243000000 | JPY |
| Valuation difference on available for sale securities | InterimInstant | 3097000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -1651000000 | JPY |
| Foreign currency translation adjustment | InterimInstant | 56000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 645000000 | JPY |
| Remeasurements of defined benefit plans | InterimInstant | 640000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 1238000000 | JPY |
| Valuation and translation adjustments | InterimInstant | 3794000000 | JPY |
| Non controlling interests | Prior1YearInstant | 6622000000 | JPY |
| Non controlling interests | InterimInstant | 6354000000 | JPY |
| Net assets | Prior1YearInstant | 151107000000 | JPY |
| Net assets | InterimInstant | 160492000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 248205000000 | JPY |
| Liabilities and net assets | InterimInstant | 259068000000 | JPY |
| Net sales | Prior1InterimDuration | 96177000000 | JPY |
| Net sales | InterimDuration | 102919000000 | JPY |
| Cost of sales | Prior1InterimDuration | 75379000000 | JPY |
| Cost of sales | InterimDuration | 80614000000 | JPY |
| Gross profit | Prior1InterimDuration | 20798000000 | JPY |
| Gross profit | InterimDuration | 22305000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |